Abstract

BackgroundFatigue is an important clinical finding in patients with chronic hepatitis virus infection. However, studies assessing fatigue in patients with chronic hepatitis B (CHB) are very limited. This study aimed to quantify the severity of fatigue in patients with CHB, to determine whether perceived fatigue reflects impairment of functional ability, and to explore potential causes.MethodsA total of 133 patients with histologically proven CHB and 59 community controls were assessed using the fatigue impact scale (FIS).ResultsThe degree of fatigue was significantly higher in patients with CHB than in controls (mean (range) FIS 24.9 (0–91) vs. 15.7 (0–31), p < 0.001). Fatigue experienced by patients with CHB was similar to that in primary biliary cirrhosis (PBC) (n = 20) (FIS 22.2 vs. 20.9, p = 0.28). No association was found between FIS and biochemistry and histological parameters of liver disease severity. Significant associations were found between fatigue severity and cognitive impairment (r = 0.39, p < 0.001), daytime somnolence (r = 0.32, p < 0.001), scores of the Chronic Liver Disease Questionnaire (r = − 0.31, p < 0.001), and autonomic symptoms (r = 0.43, p < 0.001). The level of autonomic symptom was the only factor independently associated with the degree of fatigue.ConclusionFatigue is a significant problem of functional ability impairment in CHB and similar in degree to that in PBC patients. Fatigue in patients with CHB appears to be unrelated to the severity of liver disease but is associated with significant autonomic symptoms.

Highlights

  • Fatigue is an important clinical finding in patients with chronic hepatitis virus infection

  • Phase 1: fatigue status in patients with chronic hepatitis B (CHB) compared with the control and primary biliary cirrhosis (PBC) groups Clinical and demographic data A total of 138 patients with CHB and 49 controls fulfilled the inclusion/exclusion criteria and agreed to participate in the study

  • In this study, we have shown that the degree of fatigue experienced by a cohort of treatment-naive patients with CHB is significantly greater than that experienced by age- and sex-matched community controls

Read more

Summary

Introduction

Fatigue is an important clinical finding in patients with chronic hepatitis virus infection. Studies assessing fatigue in patients with chronic hepatitis B (CHB) are very limited. Hepatitis B virus (HBV) infection is one of the most common indications for liver transplantation worldwide [2]. This hepatic manifestation of HBV has a profound negative impact on patients’ health-related quality of life [3, 4]. It is increasingly recognized that quality of life (QOL) can be significantly impaired in several chronic liver diseases (CLDs) through the impact of Objective studies using fatigue assessment tools such as the fatigue impact scale (FIS) and the fatigue severity scale (FSS) have confirmed that patients with CLD have significant fatigue [7, 8].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call